- Advertisement -
AppsEntertainmentNasdaq futures gain as yields decline and Tesla jumps,...

Nasdaq futures gain as yields decline and Tesla jumps, S&P 500 futures are flat

-

- Advertisment -spot_img


U.S. stock futures were mixed early Monday morning as Wall Street looked to bounce back from a losing week.

Futures on the tech-heavy Nasdaq 100 gained 0.8% as the 10-year yield retreated. S&P 500 futures were about flat. Futures contracts tied to the Dow Jones Industrial Average declined 65 points.

The 10-year Treasury yield fell 4 basis points to 1.68%, after touching a 14-month high last week (1 basis point equals 0.01%). The move higher in rates has raised concerns about valuations on growth and tech stocks.

Shares of Tesla added 2% in premarket trading as rates fell and as Cathie Wood’s Ark Invest put out a new price target on the stock which calls for it to quadruple in 4 years.

The three major indexes lost ground last week. The Dow and S&P 500 slipped on Friday to finish the week down 0.5% and 0.8%, respectively, breaking two-week winning streaks. The Nasdaq Composite rose on Friday but still finished the week with a 0.8% loss.

The struggles for stocks came as bond yields jumped again last week, pressuring the tech and growth stocks that led the market back from its pandemic-sparked sell-off last year.

Even with the weakness last week, the S&P 500 and Dow are still near record highs, and the Nasdaq isn’t too far off. Darrell Cronk, chief investment officer of Wells Fargo’s Wealth and Investment Management, said the stock market still appeared to be on track for a multi-year climb.

“If you went down the list and started putting boxes of check-check-check-check, you would look at this in a vacuum … and say it looks like an early recovery cycle that’s roughly a year in that probably has a number of years yet to run,” Cronk said.

Optimism about the markets and the path of the U.S. economy has been growing as vaccines are rolling out across the country, with the pace of Americans getting shots climbing in recent weeks. Several states are seeing an increase in Covid-19 cases, however.

U.S. trial data released Monday showed the Covid vaccine developed by AstraZeneca and the University of Oxford is 79% effective in preventing symptomatic illness and 100% effective against severe disease and hospitalization.

Over the weekend, the industrials sector produced a major piece of corporate news. Canadian Pacific Railway announced that it was buying Kansas City Southern in a deal valued at $25 billion, creating a rail giant that connects, Canada, the U.S. and Mexico.


LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Opinion | If you want a world where our sons and daughters are equal, stop doing all the housework

Some — usually straight — women I know turn themselves inside out to set a feminist agenda for...

As vaccinations drop, outreach workers hit the streets to change minds

DETROIT — Tanika Knighton knows how devastating Covid-19 can be: Her 62-year-old father died of the disease last...

Payment tech company Marqeta files for IPO as value tops $16 billion on private markets

Marqeta Headquarters in Oakland, Calif.Yalonda M. James | San Francisco Chronicle | Hearst Newspapers via Getty ImagesMarqeta has...

After CDC change, Walmart says employees, customers can ditch masks

Masks will no longer be required for fully vaccinated Walmart employees or customers starting Tuesday, the retailer said...
- Advertisement -spot_imgspot_img

Earnings reports and the Fed will test the market rally in the week ahead

Investors will see whether stocks carry their newfound momentum into the week ahead, as major retailers, including Walmart...

Deadly violence intensifies in Gaza Strip and Israel as Biden urges de-escalation

President Joe Biden pauses while speaking in the East Room of the White House in Washington, D.C., U.S.,...

Must read

- Advertisement -spot_imgspot_img

You might also likeRELATED
Recommended to you